Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Subclade 2.2.1-Specific Human Monoclonal Antibodies That Recognize an Epitope in Antigenic Site A of Influenza A(H5) Virus HA Detected between 2015 and 2018.

Okuda M, Yamayoshi S, Uraki R, Ito M, Hamabata T, Kawaoka Y.

Viruses. 2019 Apr 2;11(4). pii: E321. doi: 10.3390/v11040321.

2.

Aedes aegypti NeSt1 Protein Enhances Zika Virus Pathogenesis by Activating Neutrophils.

Hastings AK, Uraki R, Gaitsch H, Dhaliwal K, Stanley S, Sproch H, Williamson E, MacNeil T, Marin-Lopez A, Hwang J, Wang Y, Grover JR, Fikrig E.

J Virol. 2019 Jun 14;93(13). pii: e00395-19. doi: 10.1128/JVI.00395-19. Print 2019 Jul 1.

PMID:
30971475
3.

Loss of the TAM Receptor Axl Ameliorates Severe Zika Virus Pathogenesis and Reduces Apoptosis in Microglia.

Hastings AK, Hastings K, Uraki R, Hwang J, Gaitsch H, Dhaliwal K, Williamson E, Fikrig E.

iScience. 2019 Mar 29;13:339-350. doi: 10.1016/j.isci.2019.03.003. Epub 2019 Mar 5.

4.

Aedes aegypti AgBR1 antibodies modulate early Zika virus infection of mice.

Uraki R, Hastings AK, Marin-Lopez A, Sumida T, Takahashi T, Grover JR, Iwasaki A, Hafler DA, Montgomery RR, Fikrig E.

Nat Microbiol. 2019 Jun;4(6):948-955. doi: 10.1038/s41564-019-0385-x. Epub 2019 Mar 11.

PMID:
30858571
5.

Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene.

Wu NC, Yamayoshi S, Ito M, Uraki R, Kawaoka Y, Wilson IA.

Cell Host Microbe. 2018 Oct 10;24(4):569-578.e4. doi: 10.1016/j.chom.2018.09.010.

PMID:
30308159
6.

Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus.

Yamayoshi S, Yasuhara A, Ito M, Uraki R, Kawaoka Y.

J Clin Virol. 2018 Nov;108:105-111. doi: 10.1016/j.jcv.2018.09.016. Epub 2018 Sep 26.

PMID:
30292135
7.

Evaluation of the fusion partner cell line SPYMEG for obtaining human monoclonal antibodies against influenza B virus.

Soni P, Yasuhara A, Takenaga T, Iwatsuki-Horimoto K, Uraki R, Ito M, Sasaki T, Ikuta K, Yamayoshi S, Kawaoka Y.

J Vet Med Sci. 2018 Jun 29;80(6):1020-1024. doi: 10.1292/jvms.18-0146. Epub 2018 Apr 17.

8.

Altered vector competence in an experimental mosquito-mouse transmission model of Zika infection.

Uraki R, Hastings AK, Gloria-Soria A, Powell JR, Fikrig E.

PLoS Negl Trop Dis. 2018 Mar 5;12(3):e0006350. doi: 10.1371/journal.pntd.0006350. eCollection 2018 Mar.

9.

Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies.

Yasuhara A, Yamayoshi S, Soni P, Takenaga T, Kawakami C, Takashita E, Sakai-Tagawa Y, Uraki R, Ito M, Iwatsuki-Horimoto K, Sasaki T, Ikuta K, Yamada S, Kawaoka Y.

Sci Rep. 2017 Dec 18;7(1):17735. doi: 10.1038/s41598-017-17986-8.

10.

Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human.

Yamayoshi S, Ito M, Uraki R, Sasaki T, Ikuta K, Kawaoka Y.

J Infect. 2018 Feb;76(2):177-185. doi: 10.1016/j.jinf.2017.12.004. Epub 2017 Dec 14.

PMID:
29248585
11.

Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques.

Kiso M, Iwatsuki-Horimoto K, Yamayoshi S, Uraki R, Ito M, Nakajima N, Yamada S, Imai M, Kawakami E, Tomita Y, Fukuyama S, Itoh Y, Ogasawara K, Lopes TJS, Watanabe T, Moncla LH, Hasegawa H, Friedrich TC, Neumann G, Kawaoka Y.

J Infect Dis. 2017 Sep 1;216(5):582-593. doi: 10.1093/infdis/jix296.

PMID:
28931216
12.

Fetal Growth Restriction Caused by Sexual Transmission of Zika Virus in Mice.

Uraki R, Jurado KA, Hwang J, Szigeti-Buck K, Horvath TL, Iwasaki A, Fikrig E.

J Infect Dis. 2017 Jun 1;215(11):1720-1724. doi: 10.1093/infdis/jix204.

13.

TAM Receptors Are Not Required for Zika Virus Infection in Mice.

Hastings AK, Yockey LJ, Jagger BW, Hwang J, Uraki R, Gaitsch HF, Parnell LA, Cao B, Mysorekar IU, Rothlin CV, Fikrig E, Diamond MS, Iwasaki A.

Cell Rep. 2017 Apr 18;19(3):558-568. doi: 10.1016/j.celrep.2017.03.058.

14.

A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release.

Yamayoshi S, Uraki R, Ito M, Kiso M, Nakatsu S, Yasuhara A, Oishi K, Sasaki T, Ikuta K, Kawaoka Y.

EBioMedicine. 2017 Mar;17:182-191. doi: 10.1016/j.ebiom.2017.03.007. Epub 2017 Mar 6.

15.

Evaluation of seasonal influenza vaccines for H1N1pdm09 and type B viruses based on a replication-incompetent PB2-KO virus.

Ui H, Yamayoshi S, Uraki R, Kiso M, Oishi K, Murakami S, Mimori S, Kawaoka Y.

Vaccine. 2017 Apr 4;35(15):1892-1897. doi: 10.1016/j.vaccine.2017.02.041. Epub 2017 Mar 9.

PMID:
28285982
16.

Zika virus causes testicular atrophy.

Uraki R, Hwang J, Jurado KA, Householder S, Yockey LJ, Hastings AK, Homer RJ, Iwasaki A, Fikrig E.

Sci Adv. 2017 Feb 22;3(2):e1602899. doi: 10.1126/sciadv.1602899. eCollection 2017 Feb.

17.

Zika virus productively infects primary human placenta-specific macrophages.

Jurado KA, Simoni MK, Tang Z, Uraki R, Hwang J, Householder S, Wu M, Lindenbach BD, Abrahams VM, Guller S, Fikrig E.

JCI Insight. 2016 Aug 18;1(13). pii: e88461.

18.

A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia.

Uraki R, Piao Z, Akeda Y, Iwatsuki-Horimoto K, Kiso M, Ozawa M, Oishi K, Kawaoka Y.

J Infect Dis. 2015 Dec 15;212(12):1939-48. doi: 10.1093/infdis/jiv341. Epub 2015 Jun 29.

19.

Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts.

Yamayoshi S, Fukuyama S, Yamada S, Zhao D, Murakami S, Uraki R, Watanabe T, Tomita Y, Neumann G, Kawaoka Y.

Sci Rep. 2015 Jan 27;5:8039. doi: 10.1038/srep08039.

20.

Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine.

Uraki R, Das SC, Hatta M, Kiso M, Iwatsuki-Horimoto K, Ozawa M, Coban C, Ishii KJ, Kawaoka Y.

Vaccine. 2014 Sep 15;32(41):5295-300. doi: 10.1016/j.vaccine.2014.07.079. Epub 2014 Aug 6.

21.

Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses.

Muramoto Y, Shoemaker JE, Le MQ, Itoh Y, Tamura D, Sakai-Tagawa Y, Imai H, Uraki R, Takano R, Kawakami E, Ito M, Okamoto K, Ishigaki H, Mimuro H, Sasakawa C, Matsuoka Y, Noda T, Fukuyama S, Ogasawara K, Kitano H, Kawaoka Y.

J Virol. 2014 Aug;88(16):8981-97. doi: 10.1128/JVI.00907-14. Epub 2014 Jun 4.

22.

Virulence-affecting amino acid changes in the PA protein of H7N9 influenza A viruses.

Yamayoshi S, Yamada S, Fukuyama S, Murakami S, Zhao D, Uraki R, Watanabe T, Tomita Y, Macken C, Neumann G, Kawaoka Y.

J Virol. 2014 Mar;88(6):3127-34. doi: 10.1128/JVI.03155-13. Epub 2013 Dec 26.

23.

A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine.

Kobayashi H, Iwatsuki-Horimoto K, Kiso M, Uraki R, Ichiko Y, Takimoto T, Kawaoka Y.

Vaccine. 2013 Dec 16;31(52):6239-46. doi: 10.1016/j.vaccine.2013.10.029. Epub 2013 Oct 19.

PMID:
24144478
24.

Characterization of H7N9 influenza A viruses isolated from humans.

Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, Murakami S, Yamayoshi S, Iwatsuki-Horimoto K, Sakoda Y, Takashita E, McBride R, Noda T, Hatta M, Imai H, Zhao D, Kishida N, Shirakura M, de Vries RP, Shichinohe S, Okamatsu M, Tamura T, Tomita Y, Fujimoto N, Goto K, Katsura H, Kawakami E, Ishikawa I, Watanabe S, Ito M, Sakai-Tagawa Y, Sugita Y, Uraki R, Yamaji R, Eisfeld AJ, Zhong G, Fan S, Ping J, Maher EA, Hanson A, Uchida Y, Saito T, Ozawa M, Neumann G, Kida H, Odagiri T, Paulson JC, Hasegawa H, Tashiro M, Kawaoka Y.

Nature. 2013 Sep 26;501(7468):551-5. doi: 10.1038/nature12392. Epub 2013 Jul 10.

25.

A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges.

Uraki R, Kiso M, Iwatsuki-Horimoto K, Fukuyama S, Takashita E, Ozawa M, Kawaoka Y.

J Virol. 2013 Jul;87(14):7874-81. doi: 10.1128/JVI.00076-13. Epub 2013 May 8.

26.

Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virus.

Kiso M, Takano R, Sakabe S, Katsura H, Shinya K, Uraki R, Watanabe S, Saito H, Toba M, Kohda N, Kawaoka Y.

Sci Rep. 2013;3:1563. doi: 10.1038/srep01563.

27.

Virulence determinants of pandemic A(H1N1)2009 influenza virus in a mouse model.

Uraki R, Kiso M, Shinya K, Goto H, Takano R, Iwatsuki-Horimoto K, Takahashi K, Daniels RS, Hungnes O, Watanabe T, Kawaoka Y.

J Virol. 2013 Feb;87(4):2226-33. doi: 10.1128/JVI.01565-12. Epub 2012 Dec 5.

28.

Blocking of FcR suppresses the intestinal invasion of scrapie agents.

Uraki R, Sakudo A, Michibata K, Ano Y, Kono J, Yukawa M, Onodera T.

PLoS One. 2011 Mar 18;6(3):e17928. doi: 10.1371/journal.pone.0017928.

29.

Enhanced enteric invasion of scrapie agents into the villous columnar epithelium via maternal immunoglobulin.

Ano Y, Sakudo A, Uraki R, Sato Y, Kono J, Sugiura K, Yokoyama T, Itohara S, Nakayama H, Yukawa M, Onodera T.

Int J Mol Med. 2010 Dec;26(6):845-51.

PMID:
21042778
30.

Enhancement of phagocytotic activity by prion protein in PrP-deficient macrophage cells.

Uraki R, Sakudo A, Ando S, Kitani H, Onodera T.

Int J Mol Med. 2010 Oct;26(4):527-32.

PMID:
20818492
31.

Oxidative damage to neurons caused by the induction of microglial NADPH oxidase in encephalomyocarditis virus infection.

Ano Y, Sakudo A, Kimata T, Uraki R, Sugiura K, Onodera T.

Neurosci Lett. 2010 Jan 18;469(1):39-43. doi: 10.1016/j.neulet.2009.11.040. Epub 2009 Nov 27. Erratum in: Neurosci Lett. 2010 Jul 19;479(1):85-6.

PMID:
19945511

Supplemental Content

Support Center